The specialty pharmacy could be valued at more than $4 billion in a sale — but, a deal might slow the healthcare segment’s drive toward profitability.
The specialty pharmacy could be valued at more than $4 billion in a sale — but, a deal might slow the healthcare segment’s drive toward profitability.